David Ai, JD, MS, MBA

Chief Innovation Officer & Director of Tech Transfer, University of Hawaii

David is Chief Innovation Officer and Director of the Office of Innovation and Commercialization at the University of Hawaii System (UH), which he joined in March 2018. He was also chairman of International Strategy Committee at AUTM (Association of University Technology Managers) from 2017 to 2019, and chaired AUTM Asia Conference in 2017 which was held in Hong Kong. Prior to UH, he was Director of Knowledge Transfer at the City University of Hong Kong, 2014-2018.  David also worked for Stanford’s Office of Technology Licensing for six years, managing inventions while spearheading Stanford’s technology marketing effort in China.

Previously from 2001 to 2006, David was Vice President Chief Advisor at Hitachi Corporate VC, where he scored two successful acquisitions and one IPO among the four VC investments he led.

He founded an award-winning e-healthcare business in Beijing, and as CEO he secured $6M VC investment in the first foreign-invested cancer center in Shanghai which is now valued more than US $50M. In the 1990s, he was Corporate VP at Varian Medical (NYSE: VAR), VP of Marketing at Cirque (acquired by ALPS Japan), and a Project Manager at Hewlett-Packard.

He is a registered patent attorney (California), and an international expert in the diverse areas of innovation, law, business, technology, intellectual property, and startups and VC investments.

Close Menu